Sophia Pathai, MD, PhD, MPH
Dr Sophia Pathai is a member of the investment team at Peppermint VenturePartners GmBH, a private venture capital firm headquartered in Berlin, Germany.
She is an ophthalmologist with clinical and professional experience worldwide, including close to 10 years’ experience as a clinical ophthalmologist in the UK National Health Service, followed by clinical and translational research experience as a member of faculty at the International Centre for Eye Health, based at the London School of Hygiene & Tropical Medicine where she gained her PhD.
Dr Pathai then transitioned to the corporate biopharmaceutical and MedTech sector, where she was appointed to global leadership roles in clinical development and medical affairs at companies such as Roche, AbbVie, and Johnson & Johnson, working on high visibility drugs (>$20bn/year), and innovative surgical devices (>$1.5Bbn). She maintains a keen interest in global ophthalmology. In 2009 Sophia was a Staff Ophthalmologist onboard the Orbis Flying Eye Hospital and subsequently appointed to the Board of Trustees of Orbis UK in 2021. She also holds appointments as a scientific advisory board member for several early-stage biotech companies and non-profit organizations.
Dr Pathai holds a BSc (First Class Honours) in Tumor Biology from University College London; a MBBS (medical degree) from University College London Medical School; a Masters in Epidemiology from the London School of Hygiene & Tropical Medicine (LSHTM) and a PhD in ophthalmology and immunology and infectious diseases also awarded from LSHTM. She is Member of the Royal College of Ophthalmologists (London), a Member of the Faculty of Pharmaceutical Physicians and a Fellow of the Royal Society of Medicine. She is based in London.